America Great Health (OTCPK: AAGH)
Health Care · Biotechnology · US
$0.00
-33.33% today · -60.0% 1Y
America Great Health (OTCPK: AAGH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.23M and employs 5 people.
Over the last twelve months the share price has lost 60.0%, trading between 0.00 and 0.00.
Tweenvest scores America Great Health across four factors: quality 7/100, value 46/100, growth 100/100. Its strongest factor is growth.
AAGH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.23M
- Revenue (TTM)
- $363.33K
- P/E
- 6.67
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- -10.43
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.15B
- Employees
- 5
- Next earnings
- —
About America Great Health
Operating as a U.S.-based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio including AI cloud computing-driven diagnostic and medical devices, cell therapies, regenerative medicine, and supplements. The company, which originated as Crown Marketing, adopted the name America Great Health in March 2017. Established in 2013, AAGH's headquarters are located in Alhambra, California.
- ISIN
- US02365T1016
- Listed since
- Sep 25, 2012
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.16 | -0.14% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $444.53 | +0.16% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $549.99 | +0.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $829.99 | +0.18% |
| argenx SEENXTBR: ARGX | $63.06B | €873.60 | +1.09% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $141.20 | +1.66% |
Figures last refreshed Aug 18, 2026.